Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
...lasses of antibiotics. Mpex recently entered into a collaboration with GlaxoSmithKline focused on developing multiple drug candidates utilizing Mpex's epi technology. Company website: http://www.mpexpharma.com . ...Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
...lasses of antibiotics. Mpex recently entered into a collaboration with GlaxoSmithKline focused on developing multiple drug candidates utilizing Mpex's epi technology. Company website: http://www.mpexpharma.com . ...Eurand Announces Positive Phase III Clinical Study Results
...ancreatic enzyme replacement therapy used to treat epi and was designed to meet FDA guidelines for pancre...here are no FDA approved PEPs for the treatment of epi on the market in the US. "We are excited to p...ld alleviate serious malabsorption associated with epi in both a pediatric (younger than 7 years) and an ...Eurand to Present Zentase Phase III Data
...fibrosis, chronic pancreatitis, and pancreatic cancer -- epi results in poor digestion and reduced absorption of nutrients whi... on its lead product candidate, Zentase(TM), for the treatment of epi -- Eurand expects to initiate a rolling submission of its new drug...Eurand's Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
...sorption, common measurements for malabsorption in epi patients. In the pivotal study, the mean CFA after...stration (FDA) for Zentase as a treatment for EPI. epi is a potentially lethal disease marked by the defi... no known alternative therapies to PEPs for EPI. epi can occur as a complication of a variety of diseas...